OTCMKTS:BVNRY Bavarian Nordic A/S (BVNRY) Stock Price, News & Analysis $8.02 +0.20 (+2.56%) As of 05/2/2025 03:28 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock About Bavarian Nordic A/S Stock (OTCMKTS:BVNRY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Bavarian Nordic A/S alerts:Sign Up Key Stats Today's Range$8.01▼$8.0850-Day Range$6.84▼$8.1052-Week Range$6.60▼$14.60Volume2,765 shsAverage Volume8,676 shsMarket Capitalization$1.90 billionP/E Ratio11.62Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBavarian Nordic A/S is a fully-integrated biotechnology company focused on vaccination technology. The company’s work is built around two primary platforms that provide numerous benefits to the health industry and individuals. The company’s primary technology is MVA-BN which stands for Modified Vaccine Ankara-Bavarian Nordic. This vaccination platform is a non-replicating platform, meaning that live-virus vaccines cannot reproduce and spread within the host. This is central to the platform's high tolerance rate. MVA-BN is approved as a smallpox and monkeypox vaccine in the US, Canada, and the EU. It is also included in the US Strategic National Stockpile and is being used worldwide to control the 2022 Monkeypox outbreak.Bavarian Nordic is headquartered in Hellerup, Denmark with manufacturing sites in Denmark and Germany. The company maintains offices in Switzerland, the UK, Japan, and North Carolina in the United States. The company was incorporated in 1992 and had 4 approved products under 7 brand names available for use. Its MVA-BN non-replicating smallpox and monkeypox vaccines are available under the IMVAMUNE, IMVANEX and JYNNEOS names.The company’s second platform is the Vaccinia-Fowlpox-TRICOM platform for treating cancers. The platform can be targeted to attack specific markers found in numerous cancers. The company’s other marketable vaccines are Rabipur for rabies, MVABEA for Ebola and Marburg Hemorrhagic fever, and Encepur for tick-borne encephalitis.The company’s pipeline has 4 potential candidates for the market. These include a freeze-dried version of MVA-BN for smallpox, MVA-BN for RSV (respiratory infection), and TAEK-VAC for certain cancers. The company’s COVID-19/SARS vaccine boosters have shown effectiveness 6 months after dosing. Written by Jeffrey Neal JohnsonRead More… Receive BVNRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bavarian Nordic A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address BVNRY Stock News HeadlinesBavarian Nordic Receives Marketing Authorization for Chikungunya Vaccine for Persons Aged 12 and Older in the United KingdomMay 2 at 11:30 AM | finance.yahoo.comMHRA authorises Bavarian Nordic’s chikungunya virus vaccineMay 2 at 11:30 AM | finance.yahoo.comWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.May 4, 2025 | Altimetry (Ad)Bavarian Nordic A/S: Bavarian Nordic's Chikungunya Vaccine Receives Recommendation from U.S. CDC's Advisory Committee on Immunization Practices (ACIP)April 17, 2025 | finanznachrichten.deBavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)April 17, 2025 | finance.yahoo.comBavarian Nordic gets ACIP recommendation for its chikungunya vaccineApril 17, 2025 | seekingalpha.comBavarian Nordic's Chikungunya Vaccine Receives Recommendation from U.S. CDC's Advisory Committee on Immunization Practices (ACIP)April 16, 2025 | globenewswire.comCorrection: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/SApril 9, 2025 | globenewswire.comSee More Headlines BVNRY Stock Analysis - Frequently Asked Questions How have BVNRY shares performed this year? Bavarian Nordic A/S's stock was trading at $8.7060 at the beginning of 2025. Since then, BVNRY shares have decreased by 7.9% and is now trading at $8.02. View the best growth stocks for 2025 here. How were Bavarian Nordic A/S's earnings last quarter? Bavarian Nordic A/S (OTCMKTS:BVNRY) posted its quarterly earnings results on Wednesday, March, 5th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.07. The firm earned $299.48 million during the quarter, compared to analyst estimates of $264.06 million. Bavarian Nordic A/S had a net margin of 18.33% and a trailing twelve-month return on equity of 10.65%. How do I buy shares of Bavarian Nordic A/S? Shares of BVNRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings3/05/2025Today5/03/2025Next Earnings (Estimated)5/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:BVNRY CIKN/A Webwww.bavarian-nordic.com Phone(453) 326-8383Fax45-3326-8380Employees1,379Year Founded1994Profitability EPS (Most Recent Fiscal Year)$0.60 Trailing P/E Ratio11.62 Forward P/E Ratio11.97 P/E GrowthN/ANet Income$214.20 million Net Margins18.33% Pretax Margin18.51% Return on Equity10.65% Return on Assets7.90% Debt Debt-to-Equity RatioN/A Current Ratio1.69 Quick Ratio0.98 Sales & Book Value Annual Sales$1.02 billion Price / Sales1.85 Cash Flow$1.92 per share Price / Cash Flow4.17 Book Value$6.41 per share Price / Book1.25Miscellaneous Outstanding Shares236,565,000Free FloatN/AMarket Cap$1.90 billion OptionableNot Optionable Beta1.55 Social Links Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (OTCMKTS:BVNRY) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bavarian Nordic A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Bavarian Nordic A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.